for pharmacologic screening to identify hyperaldosteronism in patients after renal transplantation , spironolactone ( soludactone , searle ) was administered intravenously in 12 subjects ( mean dose 1.2 g in the course of 3 days ) .
C0020428
hyperaldosteronism
C0037982
spironolactone